Literature DB >> 12077637

Subtotal colectomy with antiperistaltic cecorectal anastomosis.

L Sarli1, D Iusco, V Violi, L Roncoroni.   

Abstract

We assessed the functional results achieved with an antiperistaltic end-to-end cecorectal anastomosis (CRA) after subtotal colectomy. A total of 34 patients with colonic cancer, inflammatory bowel disease or chronic constipation were treated with subtotal colectomy and cecorectal anastomosis. The postoperative mortality was nil; no major postoperative complication was registered. At a mean 60-month follow-up (range, 12-92), 32 patients were alive, showed no diarrhea nor incontinence, were completely relieved from previous symptoms and abdominal discomfort, and had a normal diet. In conclusion, subtotal colectomy with end-to-end antiperistaltic CRA seems to have a role in selected cases for the treatment of inflammatory bowel diseases, colon tumors and slow-transit constipation.

Entities:  

Mesh:

Year:  2002        PMID: 12077637     DOI: 10.1007/s101510200004

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  3 in total

Review 1.  Cecorectal (CRA) versus ileorectal (IRA) anastomosis after colectomy for slow transit constipation (STC): a meta-analysis.

Authors:  Konstantinos Perivoliotis; Ioannis Baloyiannis; George Tzovaras
Journal:  Int J Colorectal Dis       Date:  2022-01-12       Impact factor: 2.571

2.  A prospective comparison of short term results and functional recovery after laparoscopic subtotal colectomy and antiperistaltic cecorectal anastomosis with short colonic reservoir vs. long colonic reservoir.

Authors:  Dong Wei; Jian Cai; Yang Yang; Ting Zhao; Hui Zhang; Changshan Zhang; Yuanyao Zhang; Jianfeng Zhang; Fengbo Cai
Journal:  BMC Gastroenterol       Date:  2015-03-18       Impact factor: 3.067

3.  Subtotal colonic bypass plus colostomy with antiperistaltic cecoproctostomy for the treatment of slow transit constipation in an aged population: A retrospective control study.

Authors:  Yang Yang; Yong-Li Cao; Wen-Hang Wang; Yuan-Yao Zhang; Nan Zhao; Dong Wei
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.